Developer docs
API playgroundTry for free, no card

Search company profiles

Biobase

Full company profile

uuid002kgrc

Namestring
Biobase
Legal namestring
Brüller GmbH
Websiteurl
biobase.de
Company typeenum
Private
Founded yearint
1997
Descriptiontext

Biobase (legal entity Brüller GmbH) is a German bioinformatics company founded in 1997 as a spin-off from the German Research Center for Biotechnology (GBF) in Braunschweig. The company develops, curates, and licenses manually curated molecular biology databases and integrated software platforms for academic and pharmaceutical research, with proprietary products including TRANSFAC (eukaryotic transcription factors), TRANSPATH (signal transduction pathways), BRENDA (enzymology with 80,000+ entries), and the integrated BioKnowledge Library (BKL). Data assets span transcription factors, enzymes, promoter sequences, pathways, and proteomes across yeast, worm, human, and rodent species, supplemented by tools such as MATCH, ExPlain, Pathway Builder, and Array Analyzer for gene regulation and pathway analysis.

Biobase operates a B2B subscription-based licensing model, charging institutional annual fees via quote-based pricing to academic institutions, pharmaceutical companies, and biotechnology firms globally. Distribution is conducted through three wholly-owned subsidiaries in the United States (Beverly, Massachusetts), India, and Japan, alongside direct sales from its German headquarters. In addition to proprietary databases, Biobase distributes selected third-party bioinformatics products (QIAGEN-integrated databases, CLC Genomics Workbench, HGMD, QCI Interpret) and offers Knowledge Process Outsourcing services for gene expression content.

The company employs approximately 150 staff and traces its primary assets to foundational acquisitions: exclusive worldwide BRENDA marketing rights secured in 2003 and the Incyte database assets acquired in 2005 that seeded the Proteome BKL. Revenue figures are not publicly disclosed, and the company has remained privately held under Brüller GmbH since its 1999 acquisition by MBG Hannover.

Short descriptiontext

Biobase is a German bioinformatics company that develops and licenses manually curated molecular biology databases—including TRANSFAC, TRANSPATH, BRENDA, and the BioKnowledge Library—on a subscription basis to academic, pharmaceutical, and biotechnology research customers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersGermering, Germany
HQ citystring
Germering
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biological database licensing, molecular biology databases, bioinformatics software platforms, enzyme research databases, genomic data curation
Industry2 codes
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Bioinformatics Databases and Software
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Database Licensing
TypeSubscription Recurring
Description

Biobase licenses its biological databases including TRANSFAC, TRANSPATH, BRENDA, and the BioKnowledge Library to research institutions, pharmaceutical companies, and academic researchers. Revenue is generated through subscription-based access to curated molecular biology databases and software platforms.

biobase.de
2Software Platform Access
TypeSubscription Recurring
Description

Access to proprietary software tools including BKL Search, MATCH-Tool, Matrix-Tool, Array Analyzer, Pathway Builder, and ExPlain system for data analysis and interpretation.

biobase.de
3Third-Party Product Distribution
TypeLicensing Royalties
Description

Distribution of third-party bioinformatics products including IPA, CLC Genomics Workbench, HGMD, and various QCI Interpret products. Revenue from reselling and distributing partner-developed databases.

biobase.de
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Subscription-based database access
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed

biobase.de
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1TRANSFAC
Description

Comprehensive database of eukaryotic transcription factors, their experimentally determined DNA binding sites, and regulated genes.

biobase.de
+3 more records
Core offering1 text field

Biobase develops, curates, and licenses manually curated molecular biology databases and bioinformatics software platforms for life sciences research and pharmaceutical R&D. Its core offering is the BioKnowledge Library (BKL), which integrates databases covering eukaryotic transcription factors (TRANSFAC), signal transduction pathways (TRANSPATH), enzymes (BRENDA with 80,000+ entries), and species-specific proteomes, delivered alongside proprietary analysis tools such as ExPlain, MATCH, Pathway Builder, and Array Analyzer. The company also distributes third-party bioinformatics products and offers Knowledge Process Outsourcing services focused on gene expression content.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Biobase offers a platform-plus-modules architecture centered on the BIOBASE Knowledge Library (BKL), which combines two main modules: the TRANSFAC Suite for eukaryotic gene regulation analysis and the PROTEOME module for protein data. The platform includes analysis tools (MATCH, FMatch, COMPOSITE MODEL, MATRIX, ExPlain, Array Analyzer, Pathway Builder, BKL Search, BKL Pathfinder, Network Analysis, and BKT). Core proprietary databases include TRANSFAC (transcription factors), TRANSPATH (signal pathways), BRENDA (enzymes with 80,000+ entries), TRANSCompel, TRANSPro, PathoDB, YPD, HumanPSD, PombePD, WormPD, and GPCR-PD, plus BRENDA sub-products (BTO, FRENDA, AMENDA, DRENDA, KENDA). Biobase distributes selected third-party products and offers Knowledge Process Outsourcing services for gene expression content.

Product and service6 records
1BIOBASE Knowledge Library (BKL)
CategoryBioinformatics software platform
Description

A comprehensive software platform combining proteomics and genomics databases, enabling researchers to cross-reference their results with existing data and access extensive expert-curated background information; targets academic and pharmaceutical researchers in molecular biology.

2TRANSFAC
CategoryBiological database
Description

A manually curated database containing comprehensive data on eukaryotic transcription factors, their experimentally determined DNA-binding sites, and the genes they regulate; serves as a reference work for eukaryotic gene regulation analysis by academic and pharmaceutical researchers.

3TRANSPATH
CategoryBiological database
Description

A complete molecular biology database system focused on signal pathways in gene regulation, providing extended analysis capabilities for identifying signaling pathways and building regulatory networks from molecules, genes, and reactions; targets life sciences researchers.

4BRENDA (Braunschweig Enzyme Database)
CategoryBiological database
Description

One of the world's largest online biochemistry databases containing molecular biological and biochemical data on over 80,000 enzymes and their metabolic pathways extracted from scientific publications; targets biochemists, enzymologists, and systems biology researchers.

5Knowledge Process Outsourcing
CategoryProfessional services
Description

Services providing specific content and analyses on gene expression topics; targets research institutions and pharmaceutical companies requiring outsourced curation and analysis expertise.

6Third-Party Bioinformatics Product Distribution
CategoryThird-party software distribution
Description

Reselling and distribution of partner-developed bioinformatics databases and software (IPA, CLC Genomics Workbench, HGMD, QCI Interpret); targets researchers requiring complementary tools alongside Biobase proprietary products.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1University of Tokyo
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Biobase maintains research partnerships with leading universities including the University of Tokyo for collaborative research in bioinformatics and molecular biology.

biobase.de
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership with Fraunhofer Institute for Toxicology and Experimental Medicine for collaborative scientific projects.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research consortium combining experimental and simulation approaches to study intracellular processes in parasite infections.

4TRANSISTOR Project Consortium
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research project focused on regulatory processes in plants, involving collaborative research with academic partners.

biobase.de
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Biobase was founded in 1997 as a spin-off from the German Research Center for Biotechnology (now part of Helmholtz Association). Maintains ongoing relationships with the research institution.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biobase

Bioinformatics Databases and Softwarebiobase.de

Biobase is a German bioinformatics company that develops and licenses manually curated molecular biology databases—including TRANSFAC, TRANSPATH, BRENDA, and the BioKnowledge Library—on a subscription basis to academic, pharmaceutical, and biotechnology research customers globally.

What Biobase does

Biobase (legal entity Brüller GmbH) is a German bioinformatics company founded in 1997 as a spin-off from the German Research Center for Biotechnology (GBF) in Braunschweig. The company develops, curates, and licenses manually curated molecular biology databases and integrated software platforms for academic and pharmaceutical research, with proprietary products including TRANSFAC (eukaryotic transcription factors), TRANSPATH (signal transduction pathways), BRENDA (enzymology with 80,000+ entries), and the integrated BioKnowledge Library (BKL). Data assets span transcription factors, enzymes, promoter sequences, pathways, and proteomes across yeast, worm, human, and rodent species, supplemented by tools such as MATCH, ExPlain, Pathway Builder, and Array Analyzer for gene regulation and pathway analysis.

Biobase operates a B2B subscription-based licensing model, charging institutional annual fees via quote-based pricing to academic institutions, pharmaceutical companies, and biotechnology firms globally. Distribution is conducted through three wholly-owned subsidiaries in the United States (Beverly, Massachusetts), India, and Japan, alongside direct sales from its German headquarters. In addition to proprietary databases, Biobase distributes selected third-party bioinformatics products (QIAGEN-integrated databases, CLC Genomics Workbench, HGMD, QCI Interpret) and offers Knowledge Process Outsourcing services for gene expression content.

The company employs approximately 150 staff and traces its primary assets to foundational acquisitions: exclusive worldwide BRENDA marketing rights secured in 2003 and the Incyte database assets acquired in 2005 that seeded the Proteome BKL. Revenue figures are not publicly disclosed, and the company has remained privately held under Brüller GmbH since its 1999 acquisition by MBG Hannover.

Biobase firmographics

Firmographics
Name
Biobase
Legal name
Brüller GmbH
Website
https://biobase.de
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
101–250 employees
Short description
Biobase is a German bioinformatics company that develops and licenses manually curated molecular biology databases—including TRANSFAC, TRANSPATH, BRENDA, and the BioKnowledge Library—on a subscription basis to academic, pharmaceutical, and biotechnology research customers globally.
Ownership category
akta.pro rank

Biobase industry classification

Industry
Product category
Bioinformatics Databases and Software
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Biological database licensing
  • Molecular biology databases
  • Bioinformatics software platforms
  • Enzyme research databases
  • Genomic data curation

Where Biobase is headquartered

Location

Headquarters

HQ city
Germering
HQ country
Germany
HQ region
Europe

Offices3 records

Markets served

Biobase business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Database Licensing: Biobase licenses its biological databases including TRANSFAC, TRANSPATH, BRENDA, and the BioKnowledge Library to research institutions, pharmaceutical companies, and academic researchers. Revenue is generated through subscription-based access to curated molecular biology databases and software platforms.
  2. Software Platform Access: Access to proprietary software tools including BKL Search, MATCH-Tool, Matrix-Tool, Array Analyzer, Pathway Builder, and ExPlain system for data analysis and interpretation.
  3. Third-Party Product Distribution: Distribution of third-party bioinformatics products including IPA, CLC Genomics Workbench, HGMD, and various QCI Interpret products. Revenue from reselling and distributing partner-developed databases.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualSubscription-based database access

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Biobase product offering

Product offering

Core offering

Biobase develops, curates, and licenses manually curated molecular biology databases and bioinformatics software platforms for life sciences research and pharmaceutical R&D. Its core offering is the BioKnowledge Library (BKL), which integrates databases covering eukaryotic transcription factors (TRANSFAC), signal transduction pathways (TRANSPATH), enzymes (BRENDA with 80,000+ entries), and species-specific proteomes, delivered alongside proprietary analysis tools such as ExPlain, MATCH, Pathway Builder, and Array Analyzer. The company also distributes third-party bioinformatics products and offers Knowledge Process Outsourcing services focused on gene expression content.

Product overview

Biobase offers a platform-plus-modules architecture centered on the BIOBASE Knowledge Library (BKL), which combines two main modules: the TRANSFAC Suite for eukaryotic gene regulation analysis and the PROTEOME module for protein data. The platform includes analysis tools (MATCH, FMatch, COMPOSITE MODEL, MATRIX, ExPlain, Array Analyzer, Pathway Builder, BKL Search, BKL Pathfinder, Network Analysis, and BKT). Core proprietary databases include TRANSFAC (transcription factors), TRANSPATH (signal pathways), BRENDA (enzymes with 80,000+ entries), TRANSCompel, TRANSPro, PathoDB, YPD, HumanPSD, PombePD, WormPD, and GPCR-PD, plus BRENDA sub-products (BTO, FRENDA, AMENDA, DRENDA, KENDA). Biobase distributes selected third-party products and offers Knowledge Process Outsourcing services for gene expression content.

Differentiator

Problem solved

Functional benefit

Brands

  • TRANSFAC: Comprehensive database of eukaryotic transcription factors, their experimentally determined DNA binding sites, and regulated genes.
  • TRANSPATH
  • BRENDA
  • Proteome BKL

Products and services

  • BIOBASE Knowledge Library (BKL) A comprehensive software platform combining proteomics and genomics databases, enabling researchers to cross-reference their results with existing data and access extensive expert-curated background information; targets academic and pharmaceutical researchers in molecular biology.
  • TRANSFAC A manually curated database containing comprehensive data on eukaryotic transcription factors, their experimentally determined DNA-binding sites, and the genes they regulate; serves as a reference work for eukaryotic gene regulation analysis by academic and pharmaceutical researchers.
  • TRANSPATH A complete molecular biology database system focused on signal pathways in gene regulation, providing extended analysis capabilities for identifying signaling pathways and building regulatory networks from molecules, genes, and reactions; targets life sciences researchers.
  • BRENDA (Braunschweig Enzyme Database) One of the world's largest online biochemistry databases containing molecular biological and biochemical data on over 80,000 enzymes and their metabolic pathways extracted from scientific publications; targets biochemists, enzymologists, and systems biology researchers.
  • Knowledge Process Outsourcing Services providing specific content and analyses on gene expression topics; targets research institutions and pharmaceutical companies requiring outsourced curation and analysis expertise.
  • Third-Party Bioinformatics Product Distribution Reselling and distribution of partner-developed bioinformatics databases and software (IPA, CLC Genomics Workbench, HGMD, QCI Interpret); targets researchers requiring complementary tools alongside Biobase proprietary products.

Companies that use Biobase

Customer profile

Segments3 records

Ideal customer profiles3 records

Biobase technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Biobase partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • University of TokyocoreStrategic or Co-development PartnerBiobase maintains research partnerships with leading universities including the University of Tokyo for collaborative research in bioinformatics and molecular biology.
  • Fraunhofer Institut Toxikologie und Experimentelle MedizincoreStrategic or Co-development PartnerResearch partnership with Fraunhofer Institute for Toxicology and Experimental Medicine for collaborative scientific projects.
  • Sysco Project ConsortiumminorStrategic or Co-development PartnerResearch consortium combining experimental and simulation approaches to study intracellular processes in parasite infections.
  • TRANSISTOR Project ConsortiumminorStrategic or Co-development PartnerResearch project focused on regulatory processes in plants, involving collaborative research with academic partners.
  • Helmholtz Association / German Research Center for Biotechnology (GBF)coreStrategic or Co-development PartnerBiobase was founded in 1997 as a spin-off from the German Research Center for Biotechnology (now part of Helmholtz Association). Maintains ongoing relationships with the research institution.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Biobase competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Biobase financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biobase leadership team

Management profile

Number of profiles

Profiles3 records

Biobase subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Biobase funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biobase M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biobase

What does Biobase do?

Biobase develops, curates, and licenses manually curated molecular biology databases and bioinformatics software platforms for life sciences research and pharmaceutical R&D. Its core offering is the BioKnowledge Library (BKL), which integrates databases covering eukaryotic transcription factors (TRANSFAC), signal transduction pathways (TRANSPATH), enzymes (BRENDA with 80,000+ entries), and species-specific proteomes, delivered alongside proprietary analysis tools such as ExPlain, MATCH, Pathway Builder, and Array Analyzer. The company also distributes third-party bioinformatics products and offers Knowledge Process Outsourcing services focused on gene expression content.

Is Biobase a public or private company?

Biobase is a private company. It is classified as private equity controlled and is currently operating.

When was Biobase founded?

Biobase was founded in 1997. It employs 101 to 250 people.

Where is Biobase based?

Biobase is headquartered in Germering, Germany, in the Europe region.

How does Biobase make money?

Three revenue lines are on record. Database Licensing is the primary driver. The others are software Platform Access and third-Party Product Distribution.

Does Biobase have an API?

No public API is recorded for Biobase.

What industry is Biobase in?

Biobase's product category is Bioinformatics Databases and Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals